Algernon Pharmaceuticals Inc (AGNPF)

[jb1965]

NaNose

I continue to believe that in light of the continuing "technical issues with the NaNose prototype devices", which have now spanned a number of months, a workable solution is likely not easy, quick or inexpensive (or some combination of these three).

I believe the company should halt further investments to continue to advance the NaNose technology and double up resources and focus on pursuing the advancement of FAIMS, where they are not limited from a licensing perspective, as to what the relevant field of application is.

JB